Aurinia Pharmaceuticals Inc.
AUPH
20 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 5 8:27 PM | GREGORY KEENAN | Proposed Sale | 9,593 | $16.52 | $158.5K | — | View → |
| Jun 4, 2026 | Jun 4 8:12 PM | GREGORY KEENAN | Proposed Sale | 25,000 | $16.34 | $408.4K | — | View → |
| Jun 2, 2026 | Jun 3 1:54 AM | Kevin TangDirector, Chief Executive Officer, 10% Owner | Purchase | 206,005 | $15.28 | $3.1M | 13,044,106(I) | View → |
| Jun 1, 2026 | Jun 3 1:54 AM | Kevin TangDirector, Chief Executive Officer, 10% Owner | Purchase | 343,620 | $15.28 | $5.3M | 12,838,101(I) | View → |
| May 29, 2026 | Jun 3 1:54 AM | Kevin TangDirector, Chief Executive Officer, 10% Owner | Purchase | 264,981 | $15.31 | $4.1M | 12,494,481(I) | View → |
| Jun 2, 2026 | Jun 2 8:13 PM | GREGORY KEENAN | Proposed Sale | 25,000 | $2,164.00 | $54.1M | — | View → |
| May 11, 2026 | May 11 8:11 PM | PETER GREENLEAF | Proposed Sale | 3,136,201 | $15.84 | $49.7M | — | View → |
| May 11, 2026 | May 11 8:10 PM | MATTHEW MAXWELL DONLEY | Proposed Sale | 717,688 | $15.84 | $11.4M | — | View → |
| May 11, 2026 | May 11 8:07 PM | JOSEPH MILLER | Proposed Sale | 500,503 | $15.84 | $7.9M | — | View → |
| Mar 3, 2026 | Mar 3 10:35 PM | Kevin TangDirector | Purchase | 184,208 | $14.22 | $2.6M | 12,229,500(I) | View → |
| Mar 2, 2026 | Mar 3 10:35 PM | Kevin TangDirector | Purchase | 199,353 | $14.26 | $2.8M | 12,045,292(I) | View → |
| Feb 27, 2026 | Mar 3 10:35 PM | Kevin TangDirector | Purchase | 516,439 | $13.99 | $7.2M | 11,845,939(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 8:14 PM | Craig A JohnsonDirector | Grant/Award | 23,931 | $15.67 | 23,931(D) | View → |
| Jun 4, 2026 | Jun 8 8:12 PM | Kathleen GoetzDirector | Grant/Award | 23,931 | $15.67 | 23,931(D) | View → |
| Jun 4, 2026 | Jun 8 8:10 PM | Tina Susan NovaDirector | Grant/Award | 23,931 | $15.67 | 23,931(D) | View → |
| Jun 4, 2026 | Jun 8 8:08 PM | Jeffrey Allen BaileyDirector | Grant/Award | 23,931 | $15.67 | 23,931(D) | View → |
| Jun 2, 2026 | Jun 3 1:54 AM | Kevin TangDirector, Chief Executive Officer, 10% Owner | Other (J) | 10,000 | $15.00 | 10,000(I) | View → |
| May 18, 2026 | May 20 9:04 PM | Michael S HearneChief Financial Officer | Grant/Award | 70,230 | $15.28 | 70,230(D) | View → |
| May 18, 2026 | May 20 9:03 PM | Ryan ColeChief Operating Officer | Grant/Award | 70,230 | $15.28 | 70,230(D) | View → |
| Feb 27, 2026 | Mar 3 9:14 PM | Joseph M MillerChief Financial Officer | Grant/Award | 95,700 | $13.97 | 95,700(D) | View → |
| Feb 27, 2026 | Mar 3 9:14 PM | Matthew Maxwell DonleyChief Operating Officer | Grant/Award | 97,256 | $13.97 | 97,256(D) | View → |
| Feb 27, 2026 | Mar 3 9:13 PM | Peter GreenleafDirector, Chief Executive Officer | Grant/Award | 328,424 | $13.97 | 328,424(D) | View → |
| Feb 27, 2026 | Mar 3 9:13 PM | Greg KeenanSVP, Chief Medical Officer | Grant/Award | 67,870 | $13.97 | 67,870(D) | View → |
| Feb 27, 2026 | Mar 3 9:12 PM | Stephen P. RobertsonEVP, General Counsel | Grant/Award | 98,813 | $13.97 | 98,813(D) | View → |